G2138
rac-Glycerol 1-phosphate disodium salt hydrate
≥85% (enzymatic)
Synonym(s):
DL-α-Glycerophosphate disodium salt hydrate
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C3H7Na2O6P · xH2O
CAS Number:
Molecular Weight:
216.04 (anhydrous basis)
PubChem Substance ID:
UNSPSC Code:
12352201
Beilstein/REAXYS Number:
5177716
MDL number:
assay
≥85% (enzymatic)
storage temp.
2-8°C
SMILES string
O.[Na+].[Na+].OCC(O)COP([O-])([O-])=O
InChI
1S/C3H9O6P.2Na.H2O/c4-1-3(5)2-9-10(6,7)8;;;/h3-5H,1-2H2,(H2,6,7,8);;;1H2/q;2*+1;/p-2
InChI key
OFNNKPAERNWEDD-UHFFFAOYSA-L
Application
rac-Glycerol 1-phosphate does not affect the growth and metabolism of E. coli at concentrations of 5-100μm.
Biochem/physiol Actions
rac-Glycerol 1-phosphate was shown to be produced in mammalian tissues by the hydrolysis of rac-glycerol 1:2-cyclic phosphate by a soluble phosphodiesterase.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Jiangwei Yao et al.
Biochimica et biophysica acta, 1831(3), 495-502 (2012-09-18)
Membrane phospholipid synthesis is a vital facet of bacterial physiology. Although the spectrum of phospholipid headgroup structures produced by bacteria is large, the key precursor to all of these molecules is phosphatidic acid (PtdOH). Glycerol-3-phosphate derived from the glycolysis via
Luana Lopes Souza et al.
The Journal of endocrinology, 211(1), 65-72 (2011-07-15)
n-3 polyunsaturated fatty acids (n-3 PUFA) from fish oil (FO) exert important lipid-lowering effects, an effect also ascribed to thyroid hormones (TH) and TH receptor β1 (TRβ1)-specific agonists. n-3 PUFA effects are mediated by nuclear receptors, such as peroxisome proliferator-activated
Heinrich Topp et al.
Pharmacology, 88(3-4), 193-200 (2011-10-12)
The primary aim of the present investigation was to determine and compare the pharmacokinetic (PK) profiles of inorganic phosphate in serum and urine after intravenous administration of sodium glycerophosphate and inorganic sodium phosphate. Additionally, study product safety profiles were evaluated.